IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES
Live / Allowed — Fourth extension granted (statement of use) (as of 03 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97867910
- Mark type
- Slogan / phrase
- Filed
- 31 Mar 2023
- Published for opposition
- 13 Feb 2024
- Attorney of record
- Matthew P. Hintz, Esq.
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing medical services for the treatment of rare genetic diseases; Providing health information in the field of rare genetic diseases; Providing medical information in the field of rare genetic diseases
Owner
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
Prosecution history
- 09 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2026 — SOU EXTENSION 4 GRANTED
- 03 Apr 2026 — SOU EXTENSION 4 FILED
- 03 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2025 — SOU EXTENSION 3 GRANTED
- 07 Oct 2025 — SOU EXTENSION 3 FILED
- 07 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2025 — SOU EXTENSION 2 GRANTED
- 03 Apr 2025 — SOU EXTENSION 2 FILED
- 03 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2024 — SOU EXTENSION 1 GRANTED